(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 9.89% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.7%.
Stevanato Group Spa's revenue in 2025 is $1,162,143,157.On average, 3 Wall Street analysts forecast STVN's revenue for 2025 to be $384,896,509,759, with the lowest STVN revenue forecast at $383,338,082,069, and the highest STVN revenue forecast at $386,281,711,519. On average, 3 Wall Street analysts forecast STVN's revenue for 2026 to be $421,400,240,521, with the lowest STVN revenue forecast at $413,252,867,775, and the highest STVN revenue forecast at $427,852,906,435.
In 2027, STVN is forecast to generate $469,695,145,422 in revenue, with the lowest revenue forecast at $467,501,051,249 and the highest revenue forecast at $471,889,239,595.